Communicating about Nicotine and Differential Risks of Tobacco Products

沟通尼古丁和烟草制品的差异风险

基本信息

  • 批准号:
    10018840
  • 负责人:
  • 金额:
    $ 45.3万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-09-16 至 2022-08-31
  • 项目状态:
    已结题

项目摘要

ABSTRACT The US Food and Drug Administration’s (FDA) potentially groundbreaking plan to reduce tobacco-related death and disease by lowering nicotine in combusted cigarettes to minimally addictive levels has many challenges. The tobacco industry and its allies argue that it would lead to a skyrocketing black market and public and political backlash. Some caution that smokers would view reduced nicotine cigarettes as less harmful, which would deter quitting, similar to how “light” and “mild” descriptors caused many health-conscious smokers to continue smoking. To maximize the benefits of this potentially life-saving policy, it is necessary to develop effective ways to communicate about nicotine in various tobacco products and about the health risks of using products that have different levels of nicotine, such as combusted cigarettes and electronic nicotine delivery systems (ENDS). One promising communication strategy is to combine messages about reduced nicotine in combusted cigarettes with messages about lower risks of other nicotine-delivering products (i.e., “modified risk claims”). Our central hypothesis is that the two types of messages in combination have greater positive impact than either type alone. This might be due to modified risk messages being able to mitigate negative emotional reactions and reactance to reduced nicotine messages. Yet this communication strategy remains virtually unexplored. Research is sorely needed to examine these two types of messages as they present both sides of the FDA’s new comprehensive plan for nicotine and tobacco regulation. This project will provide that research by pursuing these specific aims: (1) Develop preliminary messages about reduced nicotine in combusted tobacco products using qualitative focus groups; (2) Quantify the relative importance of different types of information in communications about reduced nicotine using Discrete Choice Experiment; (3) Test the impact of messages about reduced nicotine in combusted tobacco products in the context of modified risk statements for novel tobacco products in a randomized clinical trial with a nationally representative sample of adult current exclusive smokers, dual users, and young adult (18-29) non-smokers. This project will use insights from communication and decision sciences to produce data that will contribute to the science that informs FDA regulatory actions around product review, product standards, and public education on nicotine and the differential risks of tobacco products.
摘要 美国食品和药物管理局(FDA)的潜在突破性计划,以减少烟草相关的 通过将燃烧的香烟中的尼古丁降低到最低成瘾水平, 挑战烟草业及其盟友认为,这将导致黑市飙升, 公众和政治上的反弹。一些人警告说,吸烟者会认为减少尼古丁的香烟 有害,这会阻止戒烟,类似于“轻度”和“温和”的描述词如何引起许多有健康意识的人 吸烟者继续吸烟。为了最大限度地发挥这一可能挽救生命的政策的效益,有必要 制定有效的方法,宣传各种烟草产品中的尼古丁和健康风险 使用尼古丁含量不同的产品,如燃烧的香烟和电子尼古丁 递送系统(ENDS)。一种有希望的通信策略是将关于减少的信息联合收割机组合在一起, 燃烧的香烟中的尼古丁与关于其它尼古丁递送产品的低风险的信息(即, “修改的风险索赔”)。我们的中心假设是,这两种类型的信息组合在一起, 比单独使用任何一种都有积极的影响。这可能是由于修改后的风险信息能够缓解 消极的情绪反应和对减少尼古丁信息的抗拒。然而这种沟通策略 几乎没有被探索过研究是迫切需要检查这两种类型的信息,因为他们 介绍FDA关于尼古丁和烟草监管的新综合计划的两个方面。该项目将 通过追求这些具体目标提供研究:(1)制定关于减少的初步信息 使用定性焦点组对燃烧的烟草制品中的尼古丁进行定量;(2)量化以下方面的相对重要性: 使用离散选择实验在关于减少尼古丁的通信中的不同类型的信息;(3) 测试在修改后的烟草产品中减少尼古丁的信息的影响, 在一项具有全国代表性样本的随机临床试验中对新型烟草制品的风险陈述 成年人目前唯一吸烟者、双重使用者和年轻成年人(18-29岁)非吸烟者。This project will use 从通信和决策科学的见解,以产生数据,这将有助于科学, 告知FDA有关产品审查、产品标准和尼古丁公众教育的监管行动 以及烟草产品的不同风险。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Lyudmila Popova其他文献

Lyudmila Popova的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Lyudmila Popova', 18)}}的其他基金

Communicating about Nicotine and Differential Risks of Tobacco Products
沟通尼古丁和烟草制品的差异风险
  • 批准号:
    10227991
  • 财政年份:
    2019
  • 资助金额:
    $ 45.3万
  • 项目类别:
Communicating about nicotine tobacco product standard in cigar products
雪茄产品中尼古丁烟草制品标准的交流
  • 批准号:
    10394016
  • 财政年份:
    2019
  • 资助金额:
    $ 45.3万
  • 项目类别:
Communicating about Nicotine and Differential Risks of Tobacco Products
沟通尼古丁和烟草制品的差异风险
  • 批准号:
    10399859
  • 财政年份:
    2019
  • 资助金额:
    $ 45.3万
  • 项目类别:
Communicating harm of new tobacco products
传播新型烟草产品的危害
  • 批准号:
    9320618
  • 财政年份:
    2016
  • 资助金额:
    $ 45.3万
  • 项目类别:
Communicating harm of new tobacco products
传播新型烟草产品的危害
  • 批准号:
    9547782
  • 财政年份:
    2016
  • 资助金额:
    $ 45.3万
  • 项目类别:
Communicating harm of new tobacco products
传播新型烟草产品的危害
  • 批准号:
    8754747
  • 财政年份:
    2014
  • 资助金额:
    $ 45.3万
  • 项目类别:
Communicating harm of new tobacco products
传播新型烟草产品的危害
  • 批准号:
    8926918
  • 财政年份:
    2014
  • 资助金额:
    $ 45.3万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 45.3万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.3万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 45.3万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.3万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 45.3万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 45.3万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.3万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 45.3万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 45.3万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.3万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了